NICE approves apixaban for treatment of DVT and pulmonary embolism

Patients can be given apixaban (Eliquis) on the NHS for the prevention and treatment of deep vein thrombosis and pulmonary embolism, NICE has ruled.

To treat deep vein thrombosis or pulmonary embolism, patients should be prescribed 10mg of apixaban twice daily for the first 7 days. | SCIENCE PHOTO LIBRARY
To treat deep vein thrombosis or pulmonary embolism, patients should be prescribed 10mg of apixaban twice daily for the first 7 days. | SCIENCE PHOTO LIBRARY

Apixaban directly inhibits factor Xa, suppressing thrombin formation and development of thrombi. Patients take an oral dose twice daily. 

Further information
NICE technology appraisal TA341

Apixaban is already recommended by NICE for prevention of stroke and systemic embolism in adults with nonvalvular atrial fibrillation and prevention of venous thromboembolism after total hip or knee replacement in adults.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases